CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
RHHBYPhase 3

Rituximab Phase 3 Est. Readout

Rituximab
Q4 2027~Q
CT.gov
00%
Q4 '27
RHHBYPhase 2

Rituximab Phase 2 Est. Readout

Rituximab
Q4 2027~QSTALE
CT.gov
00%
Competitive Landscape

0 competitors in Large B-Cell Lymphoma

View Full Landscape
Drug Information

Target Indication

Large B-Cell Lymphoma

Clinical Trial

NCT06047080

Last updated: 8/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.